3-129530917-C-T

Variant summary

Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong

The NM_000539.3(RHO):​c.403C>T​(p.Arg135Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,894 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R135Q) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

RHO
NM_000539.3 missense

Scores

13
5
1

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:16

Conservation

PhyloP100: 1.28

Publications

62 publications found
Variant links:
Genes affected
RHO (HGNC:10012): (rhodopsin) The protein encoded by this gene is found in rod cells in the back of the eye and is essential for vision in low-light conditions. The encoded protein binds to 11-cis retinal and is activated when light hits the retinal molecule. Defects in this gene are a cause of congenital stationary night blindness. [provided by RefSeq, Aug 2017]
RHO Gene-Disease associations (from GenCC):
  • congenital stationary night blindness autosomal dominant 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • retinitis pigmentosa 4
    Inheritance: AD, AR, SD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • congenital stationary night blindness
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • fundus albipunctatus
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 19 ACMG points.

PM1
In a hotspot region, there are 4 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 7 uncertain in NM_000539.3
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr3-129530918-GG-TT is described in ClinVar as Pathogenic. ClinVar VariationId is 279882.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 125 curated pathogenic missense variants (we use a threshold of 10). The gene has 8 curated benign missense variants. Gene score misZ: 0.24182 (below the threshold of 3.09). Trascript score misZ: 1.4363 (below the threshold of 3.09). GenCC associations: The gene is linked to congenital stationary night blindness, congenital stationary night blindness autosomal dominant 1, retinitis pigmentosa 4, fundus albipunctatus, retinitis pigmentosa.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.994
PP5
Variant 3-129530917-C-T is Pathogenic according to our data. Variant chr3-129530917-C-T is described in ClinVar as Pathogenic. ClinVar VariationId is 13028.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RHONM_000539.3 linkc.403C>T p.Arg135Trp missense_variant Exon 2 of 5 ENST00000296271.4 NP_000530.1 P08100

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RHOENST00000296271.4 linkc.403C>T p.Arg135Trp missense_variant Exon 2 of 5 1 NM_000539.3 ENSP00000296271.3 P08100

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
0.00000137
AC:
2
AN:
1461894
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
727248
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000180
AC:
2
AN:
1112012
Other (OTH)
AF:
0.00
AC:
0
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:16
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Retinitis pigmentosa 4 Pathogenic:4
Jan 11, 2024
3billion
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The variant is not observed in the gnomAD v2.1.1 dataset. Predicted Consequence/Location: Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product [REVEL: 0.93 (>=0.6, sensitivity 0.68 and specificity 0.92)]. Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000013028 /PMID: 1862076 /3billion dataset). The variant has been observed in multiple (>3) similarly affected unrelated individuals (PMID: 18175313, 1862076, 25101269, 28559085). Different missense changes at the same codon (p.Arg135Gly, p.Arg135Leu, p.Arg135Pro) have been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000013024, VCV000279882, VCV001455410, VCV001456261 /PMID: 1484692, 1862076, 8406457). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -

Apr 01, 1997
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Feb 12, 2025
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 01, 2020
Centre for Genomic Medicine, Manchester, Central Manchester University Hospitals
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinitis pigmentosa Pathogenic:4
Apr 01, 2018
Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:research

- -

-
Department of Ophthalmology and Visual Sciences Kyoto University
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Jun 23, 2019
Sharon lab, Hadassah-Hebrew University Medical Center
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:research

- -

Jul 24, 2023
Ophthalmic Genetics Group, Institute of Molecular and Clinical Ophthalmology Basel
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:research

Clinical significance based on ACMG v2.0 -

not provided Pathogenic:3
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 135 of the RHO protein (p.Arg135Trp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with autosomal dominant retinitis pigmentosa (PMID: 1862076, 18175313, 25101269, 28559085). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 13028). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt RHO protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. -

Jul 22, 2025
GeneDx
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Published functional studies demonstrate a damaging effect as the variant results in the protein being retained in the ER leading to cellular apoptosis (PMID: 30635925); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 10521250, 31429209, 32531858, 18385078, 1862076, 8841304, 18175313, 26962691, 25101269, 26794436, 21094163, 25619725, 8486634, 30635925, 29785639, 30977563, 31239368, 31054281, 31456290, 11139241, 32100970, 33576794, 1882937, 33090715, 25356976, 33781268, 33946315, 32037395, 34919893, 34448047, 37712069, 33057194, 36460718, 31213501, 36729443, 36819107, 36909829, 37217489, 36284460, 34321860, 35982159, 28559085, 38219857, 38479725) -

Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RHO: PP1:Strong, PM1, PM2, PM5, PS2:Moderate, PS4:Moderate, PS3:Supporting -

Retinal dystrophy Pathogenic:3
Jan 01, 2023
Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 15, 2019
Blueprint Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 01, 2023
Dept Of Ophthalmology, Nagoya University
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:research

- -

Retinitis punctata albescens Pathogenic:1
Apr 01, 1997
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

RHO-related disorder Pathogenic:1
Aug 21, 2024
PreventionGenetics, part of Exact Sciences
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

The RHO c.403C>T variant is predicted to result in the amino acid substitution p.Arg135Trp. This variant has been reported in individuals with autosomal dominant retinitis pigmentosa (see for examples Sung et al. 1991. PubMed ID: 1862076; Beryozkin et al. 2016. PubMed ID: 26962691). Additionally, different substitutions of the same amino acid (p.Arg135Gly, p.Arg135Leu) have been reported in individuals with for retinitis pigmentosa (Bunge et al. 1993. PubMed ID: 8406457; Andreasson et al. 1992. PubMed ID: 1484692). In silico studies suggest that the substitution of the p.Arg135 codon affects endocytosis and protein interaction (Mokarzel-Falcón et al. 2008. PubMed ID: 18175313; Rakoczy et al. 2011, PubMed ID: 21094163). Given all the evidence, we interpret c.403C>T (p.Arg135Trp) as pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
BayesDel_addAF
Pathogenic
0.56
D
BayesDel_noAF
Pathogenic
0.56
CADD
Pathogenic
29
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.92
D
Eigen
Uncertain
0.65
Eigen_PC
Uncertain
0.47
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Uncertain
0.91
D
M_CAP
Pathogenic
0.67
D
MetaRNN
Pathogenic
0.99
D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
4.6
H
PhyloP100
1.3
PrimateAI
Uncertain
0.79
T
PROVEAN
Pathogenic
-7.0
D
REVEL
Pathogenic
0.93
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.97
MutPred
0.97
Loss of sheet (P = 0.3635);
MVP
0.99
MPC
0.88
ClinPred
1.0
D
GERP RS
2.0
Varity_R
0.99
gMVP
0.99
Mutation Taster
=10/90
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs104893775; hg19: chr3-129249760; COSMIC: COSV56213571; API